Multidisciplinary treatment of chronic pain with disability

BACKGROUND AND OBJECTIVE: Disabling chronic pain is especially devastating among working population and, in many cases, it does not respond to convent ional therapies. In chronic pain, the importance of psychosocial and occupa tional factors, in addition to biological ones, has prompted the developmen t of successful multidisciplinary treatment programmes in various countries . We assessed the outcome of a multidisciplinary therapeutic program for wo rk-disabled selected patients with chronic pain refractory to conventional treatment. PATIENTS AND METHOD: The study included 70 patients (58 women, mean age [SD ]: 42 [9] years) with chronic pain and sick leave (mean [SD]: 7 [4] months of work disability) diagnosed with fibromyalgia (51%), chronic low back pai n (16%), regional myofascial pain (15%),: cervicocraneal syndrome (3%), anq uilosing spondylitis (3%), and other conditions (12%). All patients had rec eived previous pharmacological treatment, physical therapy and/or other mea sures (surgery in 12% cases) without improvement. All patients underwent an intensive multidisciplinary treatment of 4 weeks' duration including medic al techniques for pain control, cognitive-behavioural therapy, physical the rapy, and occupational therapy. Average follow-up was 10 (4) months (1-24 m onths) post-discharge. RESULTS: Significant improvements were observed with regard to all relevant variables, as reflected in pre an post-discharge measures: pain (Visual-An alogue Scale 1-10 cm): 7.4 (1.5) versus 3.2 (2) (p < 0.01); anxiety (HARS), 19 (7) versus 14 (8) (p < 0.01); depression (BDI), 16 (8) versus 10 (8) (p < 0.01); functional ability (HAQ), 1.6 (0.4) versus 0.6 (0.5) (p < 0.001). At discharge, 73% of patients returned to work. In addition, 69% of treate d patients maintained the acquired improvement and their employment status at the end of follow-up. CONCLUSION: Multidisciplinary treatment of chronic pain with special attent ion to work return is useful for selected patients with a disabling chronic pain syndrome refractory to conventional treatment.